(Press-News.org) For over two decades, physicists have been working toward implementing quantum light storage—also known as quantum memory—in various matter systems. These techniques allow for the controlled and reversible mapping of light particles called photons onto long-lived states of matter. But storing light for long periods without compromising its retrieval efficiency is a difficult task.
In recent years, rare earth atoms in solid materials at cryogenic temperatures have shown to be promising for quantum memory. As part of this inquiry, researchers from The Grainger College of Engineering at the University of Illinois Urbana-Champaign have identified favorable properties in a stoichiometric europium material with a layered structure. Their observations, published in Physical Review Letters, report the growth and characterization of NaEu(IO₃)₄, a rare earth material that may have future implications in quantum memory.
Although classical memory—like the type used to store text messages between users—is relatively simple to facilitate, quantum information cannot be stored, copied, or retained in this way.
“If I want to send someone quantum information or a quantum bit, I can't make a copy of it or hold onto it locally,” said Elizabeth Goldschmidt, a professor of physics and a supporting author of the paper. “Once I send it, it’s gone. If it gets lost on the way, it’s lost forever.”
One way around this challenge is using rare earth elements such as europium, which can be used to store quantum information long-term. Photons tend to degrade when stored for long periods, but europium can both absorb and preserve photons. Scientists can dope these rare earth species into crystals to facilitate quantum light storage. However, stoichiometric — or undoped — crystals tend to have fewer defects due to the lack of intentional doping.
Leaning into this property, Illinois Grainger engineers sought to pack a crystal with as much europium as possible by pivoting to stoichiometric crystals where the europium is part of the structure, rather than a randomly distributed dopant.
By combing the literature for crystals with attractive properties and evaluating their efficacy in photonic integration, the research team zeroed in on NaEu(IO₃)₄, a layered stoichiometric europium-containing crystal that is environmentally stable with strong bonds that produce 2D layers. If a single layer of NaEu(IO₃)₄ were to be isolated, it could be integrated with a photonic chip—an important step towards building a good quantum memory. However, the behavior of europium atoms can change when they are positioned too closely together, which required careful characterization of those properties in this new and novel material. An additional benefit of the material was enhanced storage time.
“Millisecond or longer quantum memory allows us to store a quantum state for the time it takes to communicate to anyone anywhere else on earth,” Goldschmidt said. “The maximum time it takes to communicate elsewhere is some tens of microseconds or milliseconds: up to a satellite and back down, or via an optical fiber circling the earth. That’s the time scale that we’re talking about.”
So far, Illinois researchers have demonstrated storage times of up to 800 nanoseconds. Going forward, they aim to demonstrate longer storage times and isolate a single layer of their stoichiometric material in hopes of one day building a quantum memory.
“Today’s computing hardware got its start the same way: as shards and plates of crystals from the past century,” said Daniel Shoemaker, a professor of materials science and engineering whose lab grew the crystals for this research. “We don’t know what the next century will hold for quantum memory, but we know they will rely on the actions of electrons on individual atoms and ions, like the europium in our materials here. Right now, we are exploring the first few materials, so it’s an exciting time.”
END
Stoichiometric crystal shows promise in quantum memory
2025-07-08
ELSE PRESS RELEASES FROM THIS DATE:
Study sheds light on why some prostate tumors are resistant to treatment
2025-07-08
ANN ARBOR, Michigan — A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.
Treatments such as enzalutamide, which is an androgen receptor pathway inhibitor (ARPI), are standard of care for advanced prostate cancer. While many patients have long-term good response to the drugs, some will derive no benefit whatsoever. These “extreme non-responder” patients die much more quickly ...
Tree pollen reveals 150,000 years of monsoon history—and a warning for Australia’s northern rainfall
2025-07-08
Northern Australia's annual monsoon season brings relief to drought-stricken lands and revitalises crops and livestock for farmers. But a study of 150,000 years of climate records shows that the monsoon is likely to intensify — triggering a higher risk of flooding while worsening the impact of droughts in East Asia.
Led by Professor Michael Bird, researchers at James Cook University and Flinders University have assessed sediments at Girraween Lagoon near Darwin, revealing a continuous record of monsoon rainfall patterns dating back beyond the last interglacial period.
This ...
Best skin care ingredients revealed in thorough, national review
2025-07-08
Retinoids and mineral sunscreen among the most effective for multiple skin complaints
Full list of recommended ingredients for each skin concern included in study
Nearly 80 dermatologists from 43 institutions participated in a robust national ingredient review
CHICAGO --- From drugstore aisles to TikTok trends, consumers are bombarded with skin care products. But how do you know what really works, especially now with summer in full swing?
A Northwestern Medicine study offers clarity, identifying the ingredients that dermatologists agree are most effective ...
MicroRNA is awarded an Impact Factor Ranking for 2024
2025-07-08
Bentham Science Publishers is pleased to announce that MicroRNA has been awarded an Impact Factor ranking by Clarivate Analytics. The journal, currently edited by Dr. Alberto Izzoti (University of Genoa), has been providing readers with cutting-edge research on molecular biology and the therapeutic applications of MicroRNAs. Bentham Science extends its heartfelt congratulations to all journal contributors, including editors, authors and staff who have supported the journal since its inception.
Impact Factor Update: With MicroRNA’s addition to the Impact Factor list, ...
From COVID to cancer, new at-home test spots disease with startling accuracy
2025-07-08
Got a sore throat and the sniffles? The recent rise of rapid at-home tests has made it easier to find out if you have a serious illness like COVID-19 or just a touch of spring allergies.
But while quick and convenient, these at-home tests are less sensitive than those available at the doctor’s office, meaning that you may still test negative even if you are infected.
A solution may come in the form of a new, low-cost biosensing technology that could make rapid at-home tests up to 100 times more sensitive to ...
Now accepting submissions: Special Collection on Cognitive Aging
2025-07-08
In this special collection, Aging seeks to bring together cutting-edge research that spans the cellular and molecular underpinnings of cognitive aging with insights into the psychosocial, behavioral, and environmental factors that modulate its course.
BUFFALO, NY — July 8, 2025 — As populations worldwide continue to age, understanding the mechanisms and manifestations of cognitive aging is increasingly urgent for science, medicine, and society. Age-related cognitive decline ranges from mild memory lapses to the onset of dementia, and is shaped by a complex interplay of molecular, cellular, systemic, and social ...
Young adult literature is not as young as it used to be
2025-07-08
OXFORD, Miss. – Despite its name, the young adult genre is increasingly dominated by stories about older teens and even adults. But as protagonists get older, younger readers are getting left behind, a University of Mississippi study indicates.
Ally Watkins, research and instruction librarian at the J.D. Williams Library, published her research into the increasing age of young adult protagonists in the New Review of Children's Literature and Librarianship.
“I think it's important for any reader to see themselves ...
Can ChatGPT actually “see” red? New results of Google-funded study are nuanced
2025-07-08
ChatGPT works by analyzing vast amounts of text, identifying patterns and synthesizing them to generate responses to users’ prompts. Color metaphors like “feeling blue” and “seeing red” are commonplace throughout the English language, and therefore comprise part of the dataset on which ChatGPT is trained.
But while ChatGPT has “read” billions of words about what it might mean to feel blue or see red, it has never actually seen a blue sky or a red apple in the ways that humans have. Which begs the questions: Do embodied experiences — the capacity ...
Turning quantum bottlenecks into breakthroughs
2025-07-08
Quantum computers have operated under a significant limitation: they can run only one program at a time. These million-dollar machines demand exclusive use even for the smallest tasks, leaving much of their expensive and fast-running hardware idle and forcing researchers to endure long queues.
Columbia Engineering researchers have developed HyperQ, a novel system that enables multiple users to share a single quantum computer simultaneously through isolated quantum virtual machines (qVMs). This key development brings quantum computing closer to real-world usability—more practical, ...
Cancer-fighting herpes virus shown to be an effective treatment for some advanced melanoma
2025-07-08
LOS ANGELES — The herpes simplex virus type 1 (HSV-1), which affects almost two-thirds of the world’s population and is generally associated with oral herpes, may cause painful cold sores or fever blisters around the mouth.
Yet, when genetically engineered to fight cancer, the virus may also play an important role in treating advanced melanoma, skin cancer that has spread to other parts of the body, according to phase 1-2 clinical trial results published in the Journal of Clinical ...